Deposition Diseases


Introduction

The cutaneous deposition disorders are a heterogeneous group of conditions characterized by the presence of primarily endogenous substances within the dermis or the subcutis. Deposition disorders can be associated with localized or generalized cutaneous findings, and skin involvement is sometimes the earliest sign of a deposition disease. Histologic examination of cutaneous lesions, with the use of special stains including immunohistochemistry, is a very helpful diagnostic tool ( Table 48.1 ). In addition, specific enzymatic assays or genetic mutational analysis can then be performed to establish the precise diagnosis.

Table 48.1
Disorders with dermal deposits – histologic features.
BMZ, basement membrane zone; ECM1, extracellular matrix protein 1; EPP, erythropoietic protoporphyria.
DISORDERS WITH DERMAL DEPOSITS – HISTOLOGIC FEATURES
Disease Microscopic findings Histochemical stains Special processing
Gout Dermal deposits of amorphous material with needle-like clefts surrounded by giant cells
Polarizing light/fresh preparation – fine, needle-like crystals; negative birefringence
20% silver nitrate solution: urate crystals appear black and the surrounding tissue yellow
De Galantha stain: crystals brown–black
Best fixative to preserve crystals: ethanol-based (Carnoy's fluid)
Lipoid proteinosis Masses of amorphous or laminated hyalin-like material
Also surrounds capillaries in the papillary dermis and appendages
Contains type IV collagen and laminin PAS-positive and diastase-resistant
⊕ Alcian blue, hyaluronidase-sensitive Sudan III (+/−)
Congo red (usually −)
Direct immunofluorescence with anti-ECM1 antibodies to assess protein expression
Colloid milium (adult form) Nodules of amorphous eosinophilic material
Artifactual clefts
Solar elastosis
Stains similarly to amyloid (but not all cases)
⊕ Congo red
⊕ Thioflavin T
⊕ Crystal violet
Mucopolysaccharidoses Granules within fibroblasts
Large vacuolated cells in sweat glands and the external root sheath of hair follicles (gargoyle cells)
Granules within fibroblasts:
⊕ Metachromasia with toluidine blue and Giemsa
⊕ Alcian blue
⊕ Colloidal iron (see Table 46.1 )
Fixation in absolute alcohol better than in formalin (consider when clinical diagnosis not supported by histologic findings)
Mucinoses, e.g. papular mucinosis, scleredema, pretibial myxedema ( Ch. 46 ) Mucin between collagen and variable fibroblast proliferation ⊕ Metachromasia with toluidine blue
⊕ Alcian blue
⊕ Colloidal iron (see Table 46.1 )
Fixation in absolute alcohol better than in formalin
Amyloidosis ( Ch. 47 ) Fractured, amorphous, faintly eosinophilic material in dermis ⊕ Congo red
⊕ Thioflavin T
⊕ Crystal violet
In glutaraldehyde for electron microscopy
Ochronosis ( Ch. 67 ) Sausage- or banana-shaped brown/yellow/orange structures Black staining with methylene blue or cresyl violet
Calcinosis cutis ( Ch. 50 ) Irregular masses of deeply basophilic material
Variable granulomatous inflammation
⊕ von Kossa
⊕ Alizarin red (more specific)
May fracture microtome blade
May need decalcification solution first
Porphyrias, in particular EPP ( Ch. 49 ) Perivascular rim of delicate eosinophilic fibrillar material
In chronic lesions, also dense homogeneous deposits
PAS-positive and diastase-resistant
Immunohistochemistry for BMZ components (type IV collagen)

This chapter will focus on gout, pseudogout, lipoid proteinosis, colloid milium, and the mucopolysaccharidoses. Additional deposition disorders such as papular mucinosis, amyloidosis, porphyria, and calcinosis cutis are reviewed in Chapter 46, Chapter 47, Chapter 49, Chapter 50 .

Gout

Synonyms

▪ Urate crystal arthropathy ▪ Podagra ▪ Urate deposition disease

Key features

  • Gout is a metabolic disease in which the underlying abnormality is hyperuricemia

  • Deposits of needle-like crystals of monosodium urate are found in several sites, most commonly the skin (as tophi) and the joints

  • In fresh preparations of synovial fluid and expressed material from tophi, the crystals exhibit negative birefringence when examined by polarized light

  • In routinely fixed histologic sections, amorphous deposits that contain needle-like clefts are seen in the dermis and subcutis

Introduction

Gout is a metabolic disease in which needle-like crystals of monosodium urate (the ionized form of uric acid) from supersaturated fluids are deposited in tissue. Clinical manifestations include gouty arthritis, accumulation of crystals in connective tissue (tophi), uric acid nephrolithiasis, and renal impairment .

Epidemiology

Gout is the most common form of crystal-induced arthritis, and its prevalence seems to have increased over the past few decades. Men 40–50 years of age are most commonly affected. The male-to-female ratio is 9 : 1, and most women with gout are postmenopausal. Gout is found in up to 4% of adults and ~20% of patients have a family history of gout .

Pathogenesis

Gout is a consequence of deposits of urate crystals that have precipitated from supersaturated body fluids. Uric acid is the end product of the catabolism of purines. When the body increases its production of uric acid or if the kidneys do not excrete sufficient amounts, the result is hyperuricemia ( Table 48.2 ).

Table 48.2
Classification of hyperuricemia.
ATP, adenosine triphosphate.
CLASSIFICATION OF HYPERURICEMIA
Overproduction of uric acid
  • Primary idiopathic

  • Excessive dietary purine intake and obesity

  • Increased nucleotide turnover

    • -

      High-grade lymphomas (e.g. Burkitt) and myeloma

    • -

      Myeloproliferative disorders, esp. acute myelogenous leukemia

    • -

      Tumor lysis syndrome

    • -

      Hemolysis

    • -

      Psoriasis (severe)

  • Accelerated ATP degradation

    • -

      Alcohol abuse

    • -

      Severe muscle exertion

  • Hypoxanthine–guanine phosphoribosyl transferase deficiency (Lesch–Nyhan syndrome)

  • Phosphoribosyl pyrophosphatase synthetase overactivity

Decreased excretion of uric acid
  • Primary idiopathic

  • Renal insufficiency

  • Enhanced tubular urate reabsorption (e.g. diuretics, dehydration)

  • Drug ingestion (e.g. cyclosporine > tacrolimus, pyrazinamide, low-dose salicylates)

  • Toxins (e.g. lead-induced nephropathy)

  • Miscellaneous – lactic acidosis, hypertension, hyperparathyroidism, hypothyroidism

Urate crystals can activate the NLRP3 (cryopyrin) inflammasome (see Fig. 4.2 ) and stimulate the production of the proinflammatory cytokine interleukin-1β by monocytes and macrophages . The subsequent migration and activation of neutrophils as well as complement activation initiate a vicious cycle. The ingestion of crystals by neutrophils triggers cell damage and leakage of lysosomes, which then result in further inflammation and tissue damage.

Clinical Features

The typical patient with gout is a middle-aged or older man, who may have a family history of the disease. Risk factors include obesity, excessive alcohol intake, renal insufficiency and certain medications, most commonly diuretics. The natural history of gout involves four clinical stages : (1) asymptomatic hyperuricemia; (2) acute gouty arthritis; (3) intercritical gout (the intervals between attacks, which progressively become shorter in duration); and (4) chronic tophaceous gout.

Acute gouty arthritis

The most common symptom of gout is the development of severe joint pain over a period of 6–12 hours, accompanied by tenderness, erythema, warmth, and swelling. Initial attacks are often monoarticular, but in up to 40% of patients they may be polyarticular . In 75% of patients, the first metatarsophalangeal joint is involved (referred to as podagra); additional sites include the knee, ankle and foot, and, less commonly, the hand, wrist and elbow. Fever and systemic symptoms may accompany an acute attack of gout. As the swelling subsides, the skin acquires a violaceous hue often followed by desquamation.

Chronic tophaceous gout

Cutaneous deposits of monosodium urate, known as “tophi”, usually appear an average of 10 years after the onset of gout. These tophi present as firm dermal or subcutaneous papules and nodules or as a fusiform swelling. Their contours may be smooth or multilobulated ( Fig. 48.1 ) and they vary from skin-colored to white–yellow to red ( Fig. 48.2 ). The surface may be ulcerated and there may be associated drainage of material, which varies from clear fluid with white flecks to a thick chalky material.

Fig. 48.1, Tophaceous gout of a digit.

Fig. 48.2, Tophaceous gout of the tragus.

The most common locations for tophi are the skin overlying joints and the helix of the ear. Unusual sites include the eyes, nose, larynx, breast, and heart valves. However, tophi develop in fewer than 10% of patients with gout. Depending upon the size and location of the tophi, complete, partial or minimal resolution can occur when the serum uric acid level is normalized .

Elevated levels of uric acid in the urine are associated with uric acid nephrolithiasis and may cause acute renal failure when uric acid precipitates in the renal tubules and collecting ducts. The most common setting for the latter is the tumor lysis syndrome in which chemotherapy is given for a rapidly dividing chemosensitive malignancy, e.g. leukemias, lymphomas.

The initial diagnosis of gout is usually made in the setting of acute arthritis, based upon the presence of urate crystals in an aspirate of joint fluid. Hyperuricemia is usually present, but alone it is insufficient for establishing the definitive diagnosis of gout. Additional laboratory abnormalities during an acute attack include an elevated white blood cell count (in the joint fluid and blood) and an elevated ESR.

When examined by polarized light microscopy, the needle-shaped urate crystals change color from yellow to blue based upon their alignment relative to the axis of the “red plate” compensator, i.e. they exhibit negative birefringence. In patients with recurrent attacks, radiographs of involved joints often show “punched-out” erosions with sclerotic “overhanging” margins, but no osteophytes. A 24-hour urine collection for uric acid allows the identification of patients at risk for nephrolithiasis (see Table 48.2 ).

Pathology

In gouty tophi, the key histologic feature is the presence of deposits of amorphous material within the dermis and subcutis. These deposits contain needle-like clefts (which represent dissolved urate crystals) surrounded by an infiltrate composed of histiocytes, multinucleated giant cells, and lymphocytes ( Fig. 48.3 ). Secondary calcification or even ossification can occasionally be seen.

Fig. 48.3, Tophaceous gout – histologic features.

In order to preserve the crystals, the biopsy specimen needs to be placed in an ethanol-based fixative, such as Carnoy's fluid. Then, under regular or polarized light, brightly refractile brown sheaths of fine needle-like crystals can be seen. Upon staining with 20% silver nitrate solution, the crystals appear black and the surrounding tissue yellow, whereas with the De Galantha stain, the crystals appear brown to black .

Differential Diagnosis

The differential diagnosis of acute gouty arthritis includes pseudogout (see below), osteoarthritis, psoriatic arthritis, reactive arthritis (previously referred to as Reiter disease), and septic arthritis. Given its destructive nature, septic arthritis needs to be considered even in patients in whom the diagnosis of gout has been previously established. The presence of needle-shaped crystals with negative birefringence in an aspirate of joint fluid is diagnostic of gout, while Gram stain and culture exclude septic arthritis. Occasionally, patients are misdiagnosed as having cellulitis.

The differential diagnosis of cutaneous gouty tophi includes xanthomas, rheumatoid nodules, and calcinosis cutis. Examination of expressed fluid or chalky material by polarized light can provide a “bedside” diagnosis. By ultrasonography, central clear spaces are seen within tophi whereas rheumatoid nodules contain central echodense areas .

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here